Impact of desmopressin on hematoma expansion in patients presenting to the emergency department on antiplatelet therapy: Don't expand study

Overview of attention for article published in American Journal of Emergency Medicine, March 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 17 X users
video: 1 YouTube creator

bluesky: 3 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 17 X posts from 17 X users, with an upper bound of 23,401 followers.

RT @MeganARech: 🔥New @EMPHARM_NET DONT EXPAND Study: 💊Propensity-matched, 11 EDs: desmopressin (n=35) vs. controls (n=140) 😷Desmo patients…

Dr. Paige Fields, PGY2 Critical Care Pharmacy Resident at University of Chicago Medicine, presented on on the impact of 💉desmopressin on 🧠 hematoma in patients presenting to the 🏥on 💊 antiplatelet therapy #EMRx #TwitteRx @paigefields16 https://t.co/…

RT @MeganARech: 🔥New @EMPHARM_NET DONT EXPAND Study: 💊Propensity-matched, 11 EDs: desmopressin (n=35) vs. controls (n=140) 😷Desmo patients…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 13 additional X posts.